Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Johnson & Johnson (IT:1JNJ)
MILAN:1JNJ
Holding IT:1JNJ?
Track your performance easily
1JNJ Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€132.00 - €153.00
Previous Close€145.12
Volume0.00
Average Volume (3M)56.00
Market Cap
€351.56B
Enterprise Value€366.15B
Total Cash (Recent Filing)$25.48B
Total Debt (Recent Filing)$41.49B
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Oct 15, 2024Last Dividend Ex-Date
Aug 27, 2024Dividend Yield3.03%
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,407,243,667
10 Day Avg. Volume29
30 Day Avg. Volume56
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)4.92
Price to Sales (P/S)4.46
Price to Cash Flow (P/CF)17.10
P/FCF Ratio20.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.23
Enterprise Value/Gross Profit6.25
Enterprise Value/Ebitda18.03
Forecast
1Y Price Target
€156.47Price Target Upside7.82% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
Johnson & Johnson News
Bulls Say, Bears Say
Bulls Say
Drug DevelopmentApproval of two key drugs, talquetamab and aprocitentan, would likely drive the stock price.
LitigationThe pre-packaged bankruptcy deal received 83% support from ovarian cancer claimants, significantly higher than the 75% required to achieve supermajority.
Medtech GrowthManagement confident in Medtech growth acceleration.
Bears Say
Earnings GuidanceThe company lowered adjusted EPS guidance driven by recent deals.
Legal ChallengesThe settlement plan likely still faces significant legal challenges from plaintiffs opposing the terms.
Product Patent ExpiryJ&J's bestselling product Stelara has a key patent set to expire, which is expected to negatively impact sales.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.04% Insiders
18.30% Mutual Funds
0.16% Other Institutional Investors
61.20% Public Companies and
Individual Investors
1JNJ FAQ
What was Johnson & Johnson’s price range in the past 12 months?
Johnson & Johnson lowest stock price was €132.00 and its highest was €153.00 in the past 12 months.
What is Johnson & Johnson’s market cap?
Currently, no data Available
When is Johnson & Johnson’s upcoming earnings report date?
Johnson & Johnson’s upcoming earnings report date is Oct 15, 2024 which is in 8 days.
How were Johnson & Johnson’s earnings last quarter?
Johnson & Johnson released its earnings results on Jul 17, 2024. The company reported €2.568 earnings per share for the quarter, beating the consensus estimate of €2.469 by €0.099.
Is Johnson & Johnson overvalued?
According to Wall Street analysts Johnson & Johnson’s price is currently Undervalued.
Does Johnson & Johnson pay dividends?
Johnson & Johnson pays a Quarterly dividend of €1.13 which represents an annual dividend yield of 3.03%. See more information on Johnson & Johnson dividends here
What is Johnson & Johnson’s EPS estimate?
Johnson & Johnson’s EPS estimate is €2.
How many shares outstanding does Johnson & Johnson have?
Johnson & Johnson has 2,407,243,700 shares outstanding.
What happened to Johnson & Johnson’s price movement after its last earnings report?
Johnson & Johnson reported an EPS of €2.568 in its last earnings report, beating expectations of €2.469. Following the earnings report the stock price went up 3.291%.
Which hedge fund is a major shareholder of Johnson & Johnson?
Among the largest hedge funds holding Johnson & Johnson’s share is Fisher Asset Management LLC. It holds Johnson & Johnson’s shares valued at 1B.
---
Johnson & Johnson Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€156.47 (7.82% Upside)
€156.47 (7.82% Upside)
Blogger Sentiment
Bullish
IT:1JNJ Sentiment 90%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $930.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Bullish
Bullish news 67%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.32%
12-Months-Change
Fundamentals
Return on Equity
22.34%
Trailing 12-Months
Asset Growth
-5.53%
Trailing 12-Months
Company Description
Johnson & Johnson
Johnson & Johnson provides healthcare products across three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
---
1JNJ Company Deck
---
1JNJ Earnings Call
Q2 2024
0:00 / 0:00
---
1JNJ Sales Breakdown
64.30% Innovative Medicine
35.70% MedTech
---
1JNJ Stock 12 Month Forecast
Average Price Target
€156.47
▲(7.82% Upside)
Technical Analysis
Johnson & Johnson
―
Pfizer
―
Merck & Company
―
Abbott Laboratories
―
Bristol-Myers Squibb
―
Best Analysts Covering 1JNJ
1 Year
1 Year Success Rate
23/23 ratings generated profit
1 Year Average Return
+9.70%
reiterated a buy rating 5 months ago
Copying Danielle Antalffy's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +9.70% per trade.
---